Cite
HARVARD Citation
Dubinsky, M. et al. (n.d.). DOP40 Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn's disease treated with upadacitinib. Journal of Crohn's and colitis. pp. i104-i106. [Online].